CN113698413B - Coumarin derivative SS-590 as well as preparation method and application thereof - Google Patents

Coumarin derivative SS-590 as well as preparation method and application thereof Download PDF

Info

Publication number
CN113698413B
CN113698413B CN202111080767.6A CN202111080767A CN113698413B CN 113698413 B CN113698413 B CN 113698413B CN 202111080767 A CN202111080767 A CN 202111080767A CN 113698413 B CN113698413 B CN 113698413B
Authority
CN
China
Prior art keywords
coumarin derivative
serum albumin
human serum
tetrahydro
diethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111080767.6A
Other languages
Chinese (zh)
Other versions
CN113698413A (en
Inventor
岳永康
阴彩霞
霍方俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanxi University
Original Assignee
Shanxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanxi University filed Critical Shanxi University
Priority to CN202111080767.6A priority Critical patent/CN113698413B/en
Publication of CN113698413A publication Critical patent/CN113698413A/en
Application granted granted Critical
Publication of CN113698413B publication Critical patent/CN113698413B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6456Spatial resolved fluorescence measurements; Imaging
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1048Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with oxygen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N2021/6417Spectrofluorimetric devices
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention provides a coumarin derivative SS-590, a preparation method and an application thereof, wherein the coumarin derivative SS-590 is named as (E) -1,4-diethyl-8- (3- (4-hydroxy-3-methoxyphenyl) acryloyl) -1,2,3,4-tetrahydro-7H-pyran [2,3-g ] quinoxaline-7-one in Chinese, and is named as (E) -1,4-diethyl-8- (3- (4-hydroxy-3-methoxy) acryl) -1,2,3,4-tetrahydro-7H-pyrano [2,3-g ] quinoxalin-7-one in English, and is abbreviated as SS-590. The invention provides a method for specifically detecting human serum albumin, which is based on coumarin derivative SS-590 to detect human serum albumin in PBS. The human serum albumin labeled by the coumarin derivative SS-590 can be used for SDS-PAGE Gel analysis. Has wide application prospect in the field of biomolecule detection.

Description

Coumarin derivative SS-590 as well as preparation method and application thereof
Technical Field
The invention relates to the technical field of analytical chemistry, and particularly belongs to a synthetic method of coumarin derivatives SS-590 and SS-590, and application of the SS-590 in specific detection and covalent labeling of human serum albumin.
Background
Human serum albumin is a main protein in a human blood system, is synthesized by the liver and enters a blood circulation system, and plays a key role in maintaining the osmotic pressure of blood and carrying various endogenous and exogenous substances. In clinic, the reduction of the concentration of human serum albumin has indication significance for various diseases such as gastrointestinal inflammation, liver cirrhosis and the like. As an endogenous substance of a human body, the circulation time of albumin modified drug molecules in the body is obviously prolonged, the corresponding drug anaphylactic reaction is obviously weakened, and the albumin modified drug molecules are an effective way for drug optimization. Therefore, it is clinically significant to accurately analyze the concentration of human serum albumin.
In recent years, fluorescent probe-based methods have received much attention for the quantitative detection of human serum albumin. However, these probes are generally based on the non-covalent binding of a fluorescent dye to albumin to trigger a change in the fluorescent signal of the test system. Therefore, these fluorescent probes cannot be used for quantitative analysis and labeling of albumin by SDS-PAGE Gel. The development of fluorescent probes that are capable of covalently binding to human serum albumin and which are accompanied by a change in specific fluorescent signal is extremely deficient.
The invention provides a coumarin derivative SS-590 and a preparation method thereof, and realizes specific covalent labeling and detection of human serum albumin based on the derivative SS-590.
Disclosure of Invention
The invention aims to provide a coumarin derivative and a preparation method thereof, and the coumarin derivative can be used as a detection reagent for specific covalent labeling and detection of human serum albumin; the selectivity and the sensitivity are high when the human serum albumin is detected; the derivative labeled human serum albumin can be used for SDS-PAGE Gel analysis.
The invention provides a coumarin derivative, wherein the name of the coumarin derivative is (E) -1,4-diethyl-8- (3- (4-hydroxy-3-methoxyphenyl) acryloyl) -1,2,3,4-tetrahydro-7H-pyran [2,3-g ] quinoxaline-7-one, the name of the coumarin derivative is (E) -1,4-diethyl-8- (3- (4-hydroxy-3-methoxy) acryloyl) -1,2,3,4-tetrahydro-7H-pyrano [2,3-g ] quinoxalin-7-one, and the abbreviation is SS-590. The structural formula is as follows:
Figure GDA0003633182920000021
the coumarin derivative shows excellent sensitivity and selectivity to human serum albumin in PBS, and the detection process is simple, convenient and sensitive.
The preparation method of SS-590 comprises the following steps:
reacting 8-acetyl-1, 4-diethyl-1, 2,3,4-tetrahydro-7H-pyrano [2,3-g]Quinoxalin-7-ones
Figure GDA0003633182920000022
And vanillin according to a molar ratio of 1: 1.2 dissolving in ethanol, adding a catalytic amount of piperidine, and refluxing for 70h until the reaction is complete; the solvent is evaporated to dryness under reduced pressure to obtain a crude product, and then the crude product is separated by column chromatography (eluent is ethyl acetate: petroleum ether 1: 1 according to the volume ratio) to obtain a fluorescent probe SS-590
Figure GDA0003633182920000023
The application of the coumarin derivative SS-590 is as follows: the derivative can be used for specifically detecting human serum albumin, and the human serum albumin marked by the dye can be used for SDS-PAGE Gel analysis; the detection comprises fluorescence detection and SDS-PAGE Gel imaging analysis.
Compared with the prior art, the invention has the following beneficial effects:
1. the coumarin derivative is simple to synthesize, low in cost and easy for large-scale production;
2. the detection method can realize the specific detection of the human serum albumin, and other amino acids, inorganic ions, bovine serum albumin and mouse serum albumin do not interfere the determination of the human serum albumin;
3. the detection method can be used for SDS-PAGE Gel analysis of human serum albumin.
Description of the drawings:
FIG. 1SS-590 hydrogen spectrum characterization.
FIG. 2SS-590 carbon spectrum characterization.
FIG. 3SS-590 Mass Spectrometry characterization.
FIG. 4 fluorescence spectrum of the interaction of SS-590 with human serum albumin in example 2.
FIG. 5 is a graph comparing the fluorescence intensity at 590nm for example 3SS-590 with that of various analytes.
FIG. 6 example 4 SDS-PAGE Gel analysis after interaction of SS-590 with human serum albumin.
The specific implementation mode is as follows:
the present invention will be further described with reference to the following examples and drawings, but the present invention is not limited to the following examples.
Example 1
Preparation and characterization of SS-590:
Figure GDA0003633182920000031
dissolving 8-acetyl-1, 4-diethyl-1, 2,3,4-tetrahydro-7H-pyrano [2,3-g ] quinoxaline-7-one (0.5mmol,0.15g) and vanillin (0.6mmol,0.09g) in 20mL of ethanol, adding 3-5 drops of piperidine, and refluxing for 70H until the reaction is complete; the system is decompressed and the solvent is evaporated to dryness to obtain a crude product, and then the crude product is separated by column chromatography (eluent is ethyl acetate according to the volume ratio: petroleum ether-1: 1) to obtain the fluorescent probe SS-590.
1H NMR (600MHz, Chloroform-d) δ 8.52(s,1H),8.07(d, J ═ 15.6Hz,1H),7.78(d, J ═ 15.6Hz,1H), 7.23-7.18 (m,2H),6.92(d, J ═ 8.6Hz,1H),6.54(s,1H),6.43(s,1H),5.89(s,1H),3.96(s,3H), 3.59-3.55 (m,2H),3.45(q, J ═ 7.1Hz,2H),3.36(q, J ═ 7.1Hz,2H), 3.27-3.23 (m,2H),1.25(t, J ═ 7.1Hz,3H),1.21(t, J ═ 7.1H) (fig. 1H).13C NMR(151MHz,CDCl3) δ 186.73,161.52,153.39,148.12,147.96,146.70,143.38,132.50,128.26,124.20,122.83,116.37,114.59,109.71,109.35,107.79,95.49,56.06,47.77,46.36,45.46,44.51,10.62,9.70 (fig. 2). HR-MS [ SS-1+ H]+M/z theoretical 435.1914, experimental 435.1740 (FIG. 3).
Example 2
Preparing a PBS solution, preparing a DMSO solution of 2mM SS-590, and preparing an aqueous solution of 20mg/mL human serum albumin; 1950. mu.L PBS and 5. mu.L SS-590 in DMSO were added to a fluorescence cuvette, 50. mu.L human serum albumin in water was added and mixed, and the mixture was detected on a fluorescence spectrophotometer (505nm excitation) after 10 min. The fluorescence intensity at 590nm gradually increased, and the fluorescence emission pattern is shown in FIG. 4.
Example 3
Preparing PBS solution, preparing DMSO solution of 2mM SS-590, preparing aqueous solution of 20mg/mL human serum albumin, preparing aqueous solution of 20mg/mL bovine serum albumin, preparing aqueous solution of 10mg/mL mouse serum albumin, and respectively preparing 8mM Glu, Ile, Lys, Leu, Met, Phe, Ser, Hyp, Gln, Pro, Tyr, Cystine, Arg, Thr, Asp and Na2SO3,Na2S,H2O2NaClO, 4mM Hcy, 40mM Cys and 80mM GSH in water; in 27 fluorescence cuvettes, 1950. mu.L of PBS, 5. mu.L of SS-590 in DMSO were added to the fluorescence cuvettes, and 50. mu.L of PBS, Glu, Ile, Lys, Leu, Met, Phe, Ser, Hyp, Gln, Pro, Tyr, Cystine, Arg, Thr, Asp, Na, respectively2SO3,Na2S,Cys,Hcy,GSH,H2O2NaClO, Gly, mouse serum albumin, bovine serum albumin and human serum albumin solution are mixed uniformly, and the fluorescence intensity (505nm excitation) is detected on a fluorescence spectrophotometer after 10 min. Human serum onlyThe protein added group showed a significant increase in fluorescence intensity. The fluorescence emission intensity is shown in FIG. 5, where 1 blank; glu; 3. Ile; lys; 5, Leu; met; phe; ser; hyp; gln; pro; tyr; cystine; arg; thr; asp; 17.Na2SO3;18.Na2S;19.Cys;20.Hcy;21.GSH;22.H2O2(ii) a NaClO; gly; 25. mouse serum albumin; 26. bovine serum albumin; 27. human serum albumin.
Example 4
Preparing a DMSO solution of 2mM SS-590, and preparing an SDS (2%) aqueous solution of 2mg/mL human serum albumin; mu.L of human serum albumin in SDS (2%) aqueous solution was placed in 2 centrifuge tubes, and 1. mu.L of PBS and SS-590 solution were added to each tube, and 10. mu.L of loading buffer was added to each tube. Mixing for 10min, separating with 4-12% SDS-PAGE Precast Gel, performing 80V electrophoresis for 20min and 120V electrophoresis for 40min, taking out the Gel strip, washing with PBS, and imaging with Gel imager. Only the fluorescence signal is present in the stained band. The image of the fluorescence is shown in FIG. 6.

Claims (5)

1. A coumarin derivative SS-590 is characterized in that the structural formula is as follows:
Figure FDA0003633182910000011
2. the process for preparing the coumarin derivative SS-590 as claimed in claim 1, wherein the process comprises the steps of dissolving 8-acetyl-1, 4-diethyl-1, 2,3,4-tetrahydro-7H-pyrano [2,3-g ] quinoxalin-7-one and vanillin in ethanol, adding a catalytic amount of piperidine, and refluxing to completion of the reaction; the system is decompressed and the solvent is evaporated to dryness to obtain a crude product, and then the crude product is separated by column chromatography to obtain a target compound SS-590;
wherein the molar ratio of 8-acetyl-1, 4-diethyl-1, 2,3,4-tetrahydro-7H-pyrano [2,3-g ] quinoxalin-7-one and vanillin is 1: 1-1.5.
3. Process for the preparation of coumarin derivative SS-590 according to claim 2, wherein the molar ratio between 8-acetyl-1, 4-diethyl-1, 2,3,4-tetrahydro-7H-pyrano [2,3-g ] quinoxalin-7-one and vanillin is 1: 1.2.
4. the method for preparing the coumarin derivative SS-590 as claimed in claim 2, wherein the column chromatography eluent comprises ethyl acetate: petroleum ether is 1: 1.
5. use of the coumarin derivative SS-590 as claimed in claim 1 in the preparation of a reagent for the detection of human serum albumin.
CN202111080767.6A 2021-09-15 2021-09-15 Coumarin derivative SS-590 as well as preparation method and application thereof Active CN113698413B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111080767.6A CN113698413B (en) 2021-09-15 2021-09-15 Coumarin derivative SS-590 as well as preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111080767.6A CN113698413B (en) 2021-09-15 2021-09-15 Coumarin derivative SS-590 as well as preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN113698413A CN113698413A (en) 2021-11-26
CN113698413B true CN113698413B (en) 2022-07-19

Family

ID=78660944

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111080767.6A Active CN113698413B (en) 2021-09-15 2021-09-15 Coumarin derivative SS-590 as well as preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN113698413B (en)

Also Published As

Publication number Publication date
CN113698413A (en) 2021-11-26

Similar Documents

Publication Publication Date Title
EP0110186A1 (en) Aminomethylfluorescein derivatives
JPH0137694B2 (en)
CN112142639B (en) Aldehyde group-based chiral amino acid recognition probe and preparation method and application thereof
CN107033101A (en) A kind of fluorescence probe preparation method and application for detecting formaldehyde
CN107033131A (en) It is a kind of to be used to detect fluorescence probe of cysteine and its preparation method and application
CN112986412A (en) Derivatization method of amino compound and application thereof
CN109825284B (en) Ethylenediamine-beta-cyclodextrin modified Mn doped ZnS quantum dot and preparation method and application thereof
CN113698413B (en) Coumarin derivative SS-590 as well as preparation method and application thereof
CN113150575B (en) Near-infrared naphthalimide dye and preparation method and application thereof
CN111285836A (en) Preparation and application of near-infrared fluorescent probe
CN111233928B (en) Coumarin derivative Mito-Cys and preparation method and application thereof
Wang et al. Homogeneous time-resolved fluoroimmunoassay of 3, 5, 3′-triiodo-l-thyronine in human serum by using europium fluorescence energy transfer
CN108530457A (en) Amino acid detection reagent naphthalimide derivative and its synthetic method and application
CN110186891B (en) Polypeptide fluorescent probe specifically combining copper ions and cysteine
CN109734710A (en) A kind of fluorescence probe detecting cysteine and its synthetic method and application
Du et al. 6-Oxy-(acetyl piperazine) fluorescein as a new fluorescent labeling reagent for free fatty acids in serum using high-performance liquid chromatography
CN114315784A (en) Histidine-labeled fluorescent probe and preparation method and application thereof
CN108760697B (en) BODIPY derivative BDP-N3And synthesis method and application thereof
CN113121552A (en) Synthesis and application of fluorescent probe for selectively detecting cysteine
Xia et al. A long-wavelength fluorescent probe for amino compounds and its application in the determination of aliphatic amines
Wang et al. N-hydroxysuccinimidyl-fluorescein-O-acetate for precolumn fluorescence derivatization of amino acids and oligopeptides in liquid chromatography
CN111175410A (en) Application of N-methyl phenethylamine and isotope reagent thereof in detection of carboxyl compound
JP2001081082A (en) New fluorescent labeling reagent 4-acylamino-7- mercapto-2,1,3-benzoxadiazole
JPS5951349A (en) Quantitative analysis of bile acid
Liu et al. Fluorescence enhanced sensing of cysteine based on reactive probe of naphthalene-quinoline

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant